Suchergebnisse - "Zhu, Anjie"

PubPharm (16)

1

Modeling Hierarchical Uncertainty for Multimodal Emotion Recognition in Conversation

enthalten in: IEEE transactions on cybernetics | 2024

von Chen, F. | Shao, J. | Zhu, A. | +3

2

Empowering the Diversity and Individuality of Option : Residual Soft Option Critic Framework

enthalten in: IEEE transactions on neural networks and learning systems | 2023

von Zhu, A. | Chen, F. | Xu, H. | +2

3

Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting

enthalten in: Frontiers in oncology | 2023

von Zhang, R. | Chen, Y. | Liu, X. | +9

4

Surgical reduction in chest wall disease to prolong survival in breast cancer patients : a retrospective study

enthalten in: Gland surgery | 2022

von Zhu, A. | Yun, Z. | You, M. | +8

5

Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA

enthalten in: Cancer biology & medicine | 2021

von Zhu, A. | Yuan, P. | Hu, N. | +17

6

A lower apatinib dose provides equivalent efficacy and reduced toxicity: A phase II, single-arm study of apatinib and oral etoposide in metastatic breast cancer

enthalten in: ResearchSquare.com | 2020

von Hu, N. | Zhu, A. | Si, Y. | +6

7

A lower apatinib dose provides equivalent efficacy and reduced toxicity: A phase II, single-arm study of apatinib and oral etoposide in metastatic breast cancer

enthalten in: ResearchSquare.com | 2020

von Hu, N. | Zhu, A. | Si, Y. | +6

8

Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Du, F. | Wang, W. | Wang, Y. | +11

9

Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Du, F. | Wang, W. | Wang, Y. | +11

10

Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer

enthalten in: Breast cancer research and treatment | 2020

von Du, F. | Wang, W. | Wang, Y. | +11